Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMC

The role of uncoupling protein 2 in macrophages and its impact on obesity-induced adipose tissue inflammation and insulin resistance

van Dierendonck XAMH., Sancerni T., Alves-Guerra MC., Stienstra R.

Animal Study on Type 2 Diabetes, Chronic Inflammation, published in J Biol Chem (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Biol Chem (2020)
Reported sample size
—
Source database
Europe PMC
PMID
33453996
PMCID
PMC7762953
DOI
10.1074/jbc.ra120.014868
Citations
17

Abstract (original English)

The development of a chronic, low-grade inflammation originating from adipose tissue in obese subjects is widely recognized to induce insulin resistance, leading to the development of type 2 diabetes. The adipose tissue microenvironment drives specific metabolic reprogramming of adipose tissue macrophages, contributing to the induction of tissue inflammation. Uncoupling protein 2 (UCP2), a mitochondrial anion carrier, is thought to separately modulate inflammatory and metabolic processes in macrophages and is up-regulated in macrophages in the context of obesity and diabetes. Here, we investigate the role of UCP2 in macrophage activation in the context of obesity-induced adipose tissue inflammation and insulin resistance. Using a myeloid-specific knockout of UCP2 (Ucp2 ΔLysM ), we found that UCP2 deficiency significantly increases glycolysis and oxidative respiration, both unstimulated and after inflammatory conditions. Strikingly, fatty acid loading abolished the metabolic differences between Ucp2 ΔLysM macrophages and their floxed controls. Furthermore, Ucp2 ΔLysM macrophages show attenuated pro-inflammatory responses toward Toll-like receptor-2 and -4 stimulation. To test the relevance of macrophage-specific Ucp2 deletion in vivo, Ucp2 ΔLysM and Ucp2 fl/fl mice were rendered obese and insulin resistant through high-fat feeding. Although no differences in adipose tissue infla

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueMacrophagesAnimalsMice, Inbred C57BLMice, KnockoutMiceDiabetes Mellitus, Type 2Insulin ResistanceObesityCarnitine O-Palmitoyltransferase

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research